首页> 外文期刊>Hematology/Oncology Clinics of North America >Ultralarge Von Willebrand Factor-Induced Platelet Clumping and Activation of the Alternative Complement Pathway in Thrombotic Thrombocytopenic Purpura and the Hemolytic-Uremic Syndromes
【24h】

Ultralarge Von Willebrand Factor-Induced Platelet Clumping and Activation of the Alternative Complement Pathway in Thrombotic Thrombocytopenic Purpura and the Hemolytic-Uremic Syndromes

机译:超大型冯·Willebrand因子诱导的血小板凝集和血栓性血小板减少性紫癜和溶血性尿毒症综合征的替代补体途径的激活

获取原文
获取原文并翻译 | 示例
           

摘要

The molecular linkage between ultralarge (UL) von Willebrand factor (VWF) rnultimers and the alternative complement pathway (AP) has recently been described. Endothelial cell (EC)-secreted and anchored ULVWF multimers (in long stringlike structures) function as both hyperadhesive sites that initiate platelet adhesion and aggregation and activating surfaces for the AP. In vitro, the active form of C3, C3b binds to the EC-anchored ULVWF multimeric strings and initiates the assembly on the strings of 03 convertase (C3bBb) and C5 convertase (C3bBbC3b). In vivo, activation of the AP via this mechanism proceeds all the way to generation of terminal complement complexes (C5b-9).
机译:最近已经描述了超大(VL)血管性血友病因子(VWF)消旋时间和替代补体途径(AP)之间的分子联系。内皮细胞(EC)分泌并锚定的ULVWF多聚体(呈长串状结构)既充当引发血小板粘附和聚集并活化AP的表面的高粘附性位点。在体外,C3,C3b的活性形式与EC锚定的ULVWF多聚体链结合并启动03转化酶(C3bBb)和C5转化酶(C3bBbC3b)的组装。在体内,通过这种机制激活AP一直到产生末端补体复合物(C5b-9)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号